Table 2. Percent of HBZ-positive cells in PBMC subpopulations of HAM/TSP PH1624 patient.

CD4 (63%)*	CD8 (27%)	CD25 (0%)	CD19 (10%)	CD16 (4%)
15^	< 1	0	0	0

*values in parenthesis represent the percentage of positive cells with respect to the total PBMC population analyzed, as assessed by immunofluorescence and FACS analysis.

^percent of HBZ+ cells within each specific subpopulation.